Table 3.
Outcome | Treatment A N=133 | Treatment B N=140 | p-value |
---|---|---|---|
All Cause 28-Day Mortality | 8/133 (6.0%) | 16/137 (11.7%) | 0.102 |
Prolonged Lymphopenia | 13/133 (9.8%) | 5/140 (3.6%) | 0.039 |
Moderate Lymphopenia | 32/133 (24.1%) | 21/140 (15.0%) | 0.0585 |
Note: 3 patients assigned to Treatment B had unknown 28-day mortality status.